Position in LQDA
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$13,871,789
New position
Shares Held
367,562
first reported quarter
Ownership
0.413%
of shares outstanding
% of Portfolio
38.10%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 99.51355145526469.ToString("F0")%
Shared 0.ToString("F0")%
None 0.48644854473530996.ToString("F0")%
Derivatives in LQDA
reported options exposure · as of Mar 31, 2026CallValue
$377,400
CallShares
10,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Purewater Capital LLC holds $13,871,789 across 1 Drug Manufacturers - Specialty & Generic name. LQDA ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LQDA |
Liquidia Corp
This page
|
367,562 | $13,871,789 |
All Filings in LQDA
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $13,871,789 | 367,562 | Shares | Sole | 2026-05-14 | |
| 2026-03-31 | $377,400 | 10,000 | Call | Sole | 2026-05-14 | |
| No filing history on record for this holder in this stock. | ||||||